Agilent Technologies, Inc.

Jeff Trent

Zohar H Yakhini

Paul S Meltzer

Amir Ben-Dor

Edward R Dougherty

Yidong Chen

Michael L Bittner

Nick Sampas

Ashani Weeraratna

Yuan Jiang

The overexpression of certain marker genes including Wnt5a has been found useful in the identification of more aggressive forms of malignant melanoma. Therefore, the overexpression of these genes in tumor samples of malignant melanoma may be useful in the diagnosis, profiling, and treatment of patients suffering from this disease. Inhibitors of Wnt5a activity may be useful in the treatment of aggressive forms of malignant melanoma. Inhibition of Wnt5a activity may be effected by any method including anti-sense therapy, gene therapy, and pharmaceutical intervention.

Classifying cancers

Growing community of inventors

Rockville, MD, United States of America

Jeff Trent